Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Stok Raporu

Piyasa değeri: CN¥12.0b

Guangdong Marubi Biotechnology Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Guangdong Marubi Biotechnology is forecast to grow earnings and revenue by 23.9% and 21.5% per annum respectively. EPS is expected to grow by 23.4% per annum. Return on equity is forecast to be 13.6% in 3 years.

Anahtar bilgiler

23.9%

Kazanç büyüme oranı

23.4%

EPS büyüme oranı

Personal Products kazanç büyümesi26.4%
Gelir büyüme oranı21.5%
Gelecekteki özkaynak getirisi13.6%
Analist kapsamı

Good

Son güncelleme30 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Sep 26
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Aug 30
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Jun 19
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

May 29
Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

May 07
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Mar 27
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Feb 29
Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Kazanç ve Gelir Büyüme Tahminleri

SHSE:603983 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20264,31756149764612
12/31/20253,62145640060013
12/31/20242,94536718437511
9/30/20242,64132430339N/A
6/30/20242,51830546319N/A
3/31/20242,41029194374N/A
12/31/20232,22625984338N/A
9/30/20232,124228-36178N/A
6/30/20231,974188-93113N/A
3/31/20231,826187-3269N/A
12/31/20221,732174-6248N/A
9/30/20221,793226-25122N/A
6/30/20221,730176-7948N/A
3/31/20221,766213-147-13N/A
12/31/20211,787248-125-7N/A
9/30/20211,745268-62725N/A
6/30/20211,825385-519253N/A
3/31/20211,779446-434319N/A
12/31/20201,745464-387362N/A
9/30/20201,727494154327N/A
6/30/20201,780527309339N/A
3/31/20201,806514372400N/A
12/31/20191,801515459466N/A
9/30/20191,732539540544N/A
6/30/20191,662477557562N/A
3/31/20191,606440473481N/A
12/31/20181,576415505517N/A
12/31/20171,352312N/A356N/A
12/31/20161,208232N/A213N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 603983's forecast earnings growth (23.9% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 603983's earnings (23.9% per year) are forecast to grow slower than the CN market (25.8% per year).

Yüksek Büyüme Kazançları: 603983's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 603983's revenue (21.5% per year) is forecast to grow faster than the CN market (14% per year).

Yüksek Büyüme Geliri: 603983's revenue (21.5% per year) is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 603983's Return on Equity is forecast to be low in 3 years time (13.6%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y